Skip to main content
Cyber Week Sale - Get 40% off Vantage
Published loading...Updated

Burning Rock Reports Third Quarter 2025 Financial Results

Burning Rock reported Q3 revenue of US$18.5 million with a 2.3% increase year-over-year and secured Japan approval for its OncoGuide OncoScreen Plus companion diagnostic system.

  • On Nov. 20, 2025, Burning Rock Biotech Limited reported third quarter 2025 results for the three months ended September 30, 2025, including total revenues of RMB131.6 million and a net loss of RMB16.8 million.
  • The company's CDx program advanced when OncoGuide OncoScreen Plus CDx received approval from Japan's Ministry of Health, Labour and Welfare, while pharma research revenue rose to RMB42.0 million amid shifting operations.
  • Margins improved, with gross profit at RMB98.8 million and gross margin at 75.1%, while operating expenses fell to RMB115.0 million in third quarter 2025.
  • At recent conferences, Burning Rock presented therapy‑selection study results at Cell Reports Medicine and PROMISE early‑detection data at The Innovation in September 2025.
  • In evaluating performance, management reports using non‑GAAP measures like non‑GAAP gross profit and non‑GAAP gross margin to assess NGS‑based therapy selection and early detection, supported by condensed consolidated balance sheets.
Insights by Ground AI

75 Articles

Parcel Volume Increased 9.8% to 9.6 Billion

·Yuma, United States
Read Full Article

Parcel Volume Increased 9.8% to 9.6 Billion

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources are Center
63% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Inside Ottawa Valley broke the news in Ottawa, Canada on Wednesday, November 19, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal